Acetaminophen Chlorpheniramine Maleate Dextrometho

證據等級: L5

預測適應症: 0 個

ACETAMINOPHEN / CHLORPHENIRAMINE / DEXTROMETHORPHAN / PSEUDOEPHEDRINE Combination: Insufficient Data for Repurposing Prediction

One-Sentence Summary

This is a classic four-component multi-symptom cold and flu combination (Acetaminophen + Chlorpheniramine Maleate + Dextromethorphan HBr + Pseudoephedrine), widely used in OTC cold remedies worldwide. The TxGNN model did not generate any repurposing predictions for this query, as the multi-component combination string could not be resolved to a single DrugBank entity. As a result, no clinical trial or literature evidence for a new indication was retrieved, and this report primarily documents the data gap findings.

Quick Overview

Item	Content
Original Indication	Multi-symptom cold/flu relief (fever, cough, nasal congestion, runny nose) — inferred from known pharmacology
Predicted New Indication	— (No prediction generated)
TxGNN Prediction Score	N/A
Evidence Level	N/A — model produced no output
US/TW Market Status	未上市 (Not found in regulatory database)
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

TxGNN is a graph-based model that maps individual drug compounds to DrugBank node IDs within a knowledge graph. This query submitted a four-ingredient combination string as a single entity:

ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE

The system could not resolve this string to a single drugbank_id (returned null), which is the required input for the TxGNN prediction pipeline. Without a valid DrugBank node, no knowledge graph traversal or disease association scoring can occur.

Each individual ingredient is a well-characterized compound with its own DrugBank entry:

Component	Known Role	Likely DrugBank Entry
Acetaminophen (APAP)	Antipyretic / Analgesic	DB00316
Chlorpheniramine Maleate	First-generation antihistamine	DB01114
Dextromethorphan HBr	Cough suppressant (NMDA antagonist)	DB00514
Pseudoephedrine	Nasal decongestant (sympathomimetic)	DB00852

To obtain meaningful repurposing predictions, each ingredient should be submitted as a separate query to the TxGNN pipeline.

Safety Considerations

All safety data fields for this multi-component query returned gaps. However, based on established pharmacology of the four components, the following are known class-level concerns:

Acetaminophen: Hepatotoxicity risk at high doses; contraindicated with hepatic impairment and concurrent alcohol use
Pseudoephedrine: Sympathomimetic effects — contraindicated with MAOIs, hypertension, severe coronary artery disease, and hyperthyroidism
Chlorpheniramine: Anticholinergic effects — caution in elderly patients, glaucoma, BPH; sedation risk
Dextromethorphan: Serotonin syndrome risk when combined with MAOIs or serotonergic agents; CYP2D6 interactions

For complete safety information, refer to each component’s individual package insert.

Conclusion and Next Steps

Decision: Hold

Rationale: The TxGNN pipeline could not process this multi-component combination as a single entity — no DrugBank ID was resolved and no predictions were generated. There is no repurposing output to evaluate.

To proceed, the following is needed:

Decompose into individual queries: Re-submit each of the four active ingredients (Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Pseudoephedrine) as separate TxGNN candidates
Resolve DrugBank IDs: Map each component to its respective DrugBank ID before pipeline entry
Clarify the intended repurposing target: Determine whether the repurposing hypothesis is for the combination as a whole, or for one specific component within it
Review individual MOA data: Retrieve mechanism of action from DrugBank for each component separately
Retrieve safety data: Download and parse the package insert PDF from TFDA (or FDA) for each individual component to fill the DG001 and DG002 data gaps
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.